Esophageal adenocarcinoma (EAC) is a type of cancer affecting the mucus-secreting glands of the lower esophagus—the tube connecting the throat to the stomach. It is the most common form of esophageal cancer and often preceded ...
Sep 22, 2022
0
47
A new study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with eosinophilic esophagitis (EoE), which allows immediate intervention ...
Sep 16, 2022
0
34
Esophageal cancer is the seventh most common cancer world-wide and a lethal malignancy causing a considerably high number of deaths. There is currently no promising method for prevention, early detection, or screening of ...
Aug 30, 2022
0
31
Rates of most types of cancer are higher in men than in women for reasons that are unclear. Results from a recent study published in Cancer suggest that the cause may be underlying biological sex differences rather than behavioral ...
Aug 8, 2022
2
55
A new research paper was published in Oncotarget on July 28, 2022, entitled, "Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer."
Aug 2, 2022
0
2
Of the roughly 20,000 people in the U.S. diagnosed with esophageal cancer this year, just 4,000 are likely to still be alive in 2027.
Jul 28, 2022
0
8
Biomarkers are like the X on a treasure map, but instead of indicating the location of unearthed riches, they indicate an individual's health status. Common biomarkers include certain RNA or protein molecules present in tissues ...
Jun 16, 2022
0
11
A review of studies about the effect of food insecurity on digestive diseases found a dearth of information, even as diet can often be both a direct cause of and a solution for many gastrointestinal conditions.
Jun 2, 2022
0
28
An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, describes for the first time a mutation of the IL-33 gene in the human genome that results in multiple allergic disease ...
May 27, 2022
0
314
The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older.
May 26, 2022
0
0
